Multiple reports showed that STAT3, PIK3CA, AKT1, INSR, EGFR and VEGFA are primarily involved in T2DM diseases, which suggested that GP may have an anti-T2DM effect. The gene discussed is STAT3; the disease is type 2 diabetes mellitus.